Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Conditions:   Melanoma;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck;   Urothelial Carcinoma;   Renal Cell Carcinoma;   Small-cell Lung Cancer;   Cutaneous Squamous Cell Carcinoma;   Anal Squamous Cell Carcinoma
Interventions:   Biological: GEN-011;   Drug: IL-2;   Drug: Fludarabine;   Drug: Cyclophosphamide
Sponsor:   Genocea Biosciences, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Comments